Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 6, September

Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?

Volume:5   Issue: 6
Pp: 381-392
Rudolf Lucas, Matthias Kresse, Markus Latta and Albrecht Wendel
DOI: 10.2174/1568009054863627
Published on: 01 March, 2012

Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications

Volume:5   Issue: 6
Pp: 421-444
T. Robak, A. Korycka, M. Kasznicki, A. Wrzesien-Kus and P. Smolewski
DOI: 10.2174/1568009054863618
Published on: 01 March, 2012

Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies

Volume:5   Issue: 6
Pp: 445-455
Daruka Mahadevan and Nikhil Shirahatti
DOI: 10.2174/1568009054863609
Published on: 01 March, 2012

P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy

Volume:5   Issue: 6
Pp: 457-468
Albert Breier, Miroslav Barancik, Zdenka Sulova and Branislav Uhrik
DOI: 10.2174/1568009054863636
Published on: 01 March, 2012